AM Pharma
  • Home
  • About Us
    • About AM-Pharma
    • Leadership Team
    • Supervisory Board
    • Careers
  • Our approach
    • Our Product and MOA
    • Acute Kidney Injury (AKI)
    • Hypophosphatasia (HPP)
  • Partnering
  • Investors
  • Media Centre
    • Press Releases
    • Publications
  • Contact
  • Menu Menu

Home > Media Centre

Media Centre

Press releases

AM-PHARMA ANNOUNCES TWO PRESENTATIONS AT THE 27TH INTERNATIONAL CONFERENCE ON ADVANCES IN CRITICAL CARE NEPHROLOGY

7th March 2022
The lead investigator will present an overview of AM-Pharma’s…
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2022-03-07 08:00:242022-03-07 13:05:14AM-PHARMA ANNOUNCES TWO PRESENTATIONS AT THE 27TH INTERNATIONAL CONFERENCE ON ADVANCES IN CRITICAL CARE NEPHROLOGY

AM-Pharma to Participate in Upcoming Investor and Scientific Conferences

3rd March 2022
UTRECHT, The Netherlands - AM-Pharma B.V., an emerging leader…
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2022-03-03 11:23:172022-03-03 11:31:39AM-Pharma to Participate in Upcoming Investor and Scientific Conferences

AM-Pharma and Leading Experts Publish Report on State-of-the-Art Clinical Trials in Acute Kidney Injury

26th January 2022
Utrecht, The Netherlands, January 26, 2022 – AM Pharma B.V.,…
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2022-01-26 10:03:452022-01-26 10:03:45AM-Pharma and Leading Experts Publish Report on State-of-the-Art Clinical Trials in Acute Kidney Injury

AM-Pharma to Participate in Upcoming Investor Conferences

5th January 2022
Utrecht, The Netherlands, January 5, 2022 – AM-Pharma B.V.,…
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2022-01-05 19:19:412022-01-10 19:39:01AM-Pharma to Participate in Upcoming Investor Conferences

AM-Pharma Appoints Alexander Bastian as Vice President Value & Market Access

3rd November 2021
Utrecht, The Netherlands, 3 November, 2021 – AM-Pharma B.V.,…
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2021-11-03 20:48:432022-01-04 20:50:31AM-Pharma Appoints Alexander Bastian as Vice President Value & Market Access

AM-Pharma Appoints Lars Boesgaard as Chief Financial Officer and Establishes U.S. Affiliate AM-Pharma Inc.

16th September 2021
Utrecht, The Netherlands, 15 September, 2021 – AM-Pharma B.V.,…
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2021-09-16 08:10:032021-09-16 08:10:03AM-Pharma Appoints Lars Boesgaard as Chief Financial Officer and Establishes U.S. Affiliate AM-Pharma Inc.
Page 2 of 512345

Publications

Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers

4th May 2016
View publication
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2016-05-04 16:58:542021-01-07 12:21:59Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers

Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase

29th August 2015
View publication
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2015-08-29 16:56:582021-01-07 12:22:05Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase

Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate

29th July 2015
View publication
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2015-07-29 16:16:542021-01-07 12:22:10Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate

Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphatase

26th November 2014
View publication
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2014-11-26 16:24:562021-01-07 12:22:16Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphatase

Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential

24th February 2014
View publication
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2014-02-24 16:45:172021-01-07 12:22:21Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential

Alkaline Phosphatase as a Treatment of Sepsis-Associated Acute Kidney Injury

1st January 2013
Read report
Read more
/wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png 0 0 Info /wp-content/uploads/2019/06/AM_Pharma_logo-300x35.png Info2013-01-01 16:48:482021-01-07 12:22:27Alkaline Phosphatase as a Treatment of Sepsis-Associated Acute Kidney Injury
Page 2 of 41234

  • Privacy Policy
© AM-Pharma B.V.
Website by BTTR
linkedin
Scroll to top

We use cookies to help us improve our website by collecting and reporting information on how you use it. For more information about how we use cookies please see our Cookies Policy

AcceptReject


How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Accept settingsHide notification only